NDC11 73614020301
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 73614-0203-01 | 73614-0203 |
| 73614-0203-1 | 73614-0203 |
| 73614-203-01 | 73614-203 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Orapaz | CEPHALEXIN, IBUPROFEN, CHLORHEXIDINE GLUCONATE | Brisk Pharmaceuticals | 2de0b332-58a3-0bb4-e063-6394a90a1a45 | 2025-02-11 | 73614-203-01 73614020301 | |
| Chlorhexidine Gluconate Oral Rinse | CHLORHEXIDINE GLUCONATE ORAL RINSE | Brisk Pharmaceuticals | 2dcc3920-d9ed-bd56-e063-6294a90a0f3e | 2025-02-10 | Warnings, Adverse reactions | 73614-203-01 73614-203 73614020301 |
| ClindaCare | CLINDAMYCIN, IBUPROFEN, CHLORHEXIDINE GLUCONATE | Brisk Pharmaceuticals | 2df8a89c-38df-c63b-e063-6394a90aaa36 | 2025-02-10 | 73614-203-01 73614020301 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.